Nanogenics Limited
07636591
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
31/12/2024
micro entity
Next accounts due
30/09/2026
Confirmation statement
Last: 08/07/2025
Due 22/07/2026
Industry
Officers
director · Since 05/10/2023
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 62
Also on 1 other board
Persons with Significant Control
Thalia Therapeutics Plc
2, Portman Street, London, W1H 6DU
Reg: 01435584 · Companies House · Corporate
Notified 05/10/2023
Former PSCs
Prof Stephen Lewis Hart
Ceased 11/05/2018
Applisci Ltd
Ceased 11/05/2018
Ryboquin Company Ltd
Ceased 05/10/2023
CompanyRankvs 493+ SIC 72110 peers72
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2021
Net Worth
£57k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£57k
Working capital
Current Assets
£58k
Current Liabilities
£1k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2021 | 54.04 | +£17k |
| 2020 | 10.54 | — |
Derived from filed accounts. Not audited figures.